vTv Therapeutics VTVT
NASDAQ VTVT
$33.35 -0.12 (-0.36%)
At close: Sep 4, 2026 · 4:00 PM EDT

vTv Therapeutics (VTVT) Treasury Shares (2014 - 2015)

vTv Therapeutics' (VTVT) quarterly Treasury Shares came in at $1.2 billion in Q2 2015, up 4.24% quarter-over-quarter from $1.1 billion in Q4 2014.

Analysis

vTv Therapeutics (VTVT) Treasury Shares (2014 - 2015) Analysis & Trends

vTv Therapeutics has disclosed Treasury Shares across 2 years of filings, most recently posting $1.2 billion for Q2 2015.

  • In Q2 2015, Treasury Shares changed N/A year-over-year to $1.2 billion; the TTM figure through Jun 2015 stood at $1.2 billion (changed N/A YoY), while the FY2014 annual figure was $1.1 billion, changed N/A from the prior year.
  • Treasury Shares came in at $1.2 billion for Q2 2015 at vTv Therapeutics, up from $1.1 billion in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $1.2 billion in Q2 2015 to a low of $1.1 billion in Q4 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Treasury Shares (Qtr)
1 Johnson & Johnson 663.08 Bn 642.33 Bn 17.26 Bn 711.62 Mn
2 AbbVie 453.04 Bn 446.51 Bn 12.70 Bn 10.62 Bn
3 Merck 370.87 Bn 363.78 Bn 12.21 Bn 1.11 Bn
4 Novartis Ag 305.29 Bn 298.00 Bn 11.24 Bn -49.00 Mn
5 Pfizer 162.10 Bn 150.70 Bn 10.94 Bn 115.19 Bn
6 Sanofi 53.95 Bn 46.98 Bn 10.79 Bn -
7 Revolution Medicines 45.00 Bn 45.00 Bn - -
8 BeOne Medicines 40.49 Bn 35.39 Bn 1.53 Bn -
9 Incyte 25.47 Bn 20.94 Bn 1.57 Bn -
10 vTv Therapeutics 413.85 Mn 413.85 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2015 1.19 Bn
Jun 30, 2015 1.19 Bn
Dec 31, 2014 1.15 Bn
Dec 31, 2014 1.15 Bn